Wednesday, Dec 6, 2023 · SEC filings
What the smart money revealed on Dec 6
453 insider filings came in. We hid 68 planned (10b5-1) sellers and 185 people whose filings were routine, like grants and tax withholding.
Erasca (ERAS) Chairman and CEO Jonathan Lim bought $1.7M
1M shares on the open market. Not a grant or an option exercise.
Fathom (FTHM) Director Scott Flanders bought $600K
300,000 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 5 checked quarters beat the typical stock 6 months later.
Pulse Biosciences (PLSE) Director Robert Duggan bought $280K
27,000 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 6 checked quarters beat the typical stock 6 months later.
PCB Bancorp (PCB) Director Sang Lee bought $129K
8,000 shares on the open market. Not a grant or an option exercise. Their past buys: 7 of 8 checked quarters beat the typical stock 6 months later.
Gulfport Energy (GPOR) Director Robert O'Shea sold $20M
Not marked as a planned 10b5-1 sale. Sold 2% of the shares they held directly. Still holds 6.22M shares.
DraftKings (DKNG) President Paul Liberman sold $17.8M
Not marked as a planned 10b5-1 sale. Sold 30% of the shares they held directly. Still holds 1.14M shares.
TFS Financial (TFSL) COO Meredith Weil sold $211K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 49 more real buys
Show 113 more real sales
13F season
Holdings as of Sep 30, 2023 were due Nov 14
40 funds have filed. 40 filed for the quarter before.
Biggest real insider buys, Nov 30–Dec 6
Open-market buys by officers and directors, filed in the 7 days up to Dec 6.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.